A rare cause of recurrent massive hemoptysis

Area of Science:

• Vascular Medicine
• Rheumatology
• Pulmonary Medicine

Background:

• Massive hemoptysis can result from pulmonary artery aneurysmal rupture, a rare but critical condition.
• Differential diagnosis for pulmonary artery bleeding includes infections, malignancy, Behçet's disease, and Hughes-Stovin Syndrome (HSS).
• Identifying the precise etiology is crucial for effective patient management and prognosis.

Purpose of the Study:

• To highlight the importance of considering Hughes-Stovin Syndrome (HSS) in cases of pulmonary artery aneurysms.
• To emphasize specific diagnostic findings suggestive of HSS, such as aneurysmal wall enhancement and in-situ thrombus.
• To underscore the benefits of early diagnosis and multidisciplinary treatment for improving outcomes.

Main Methods:

• Review of clinical presentations and diagnostic imaging findings in patients with pulmonary artery aneurysms.
• Differential diagnosis process, excluding common causes like infections and malignancy.
• Correlation of imaging features (aneurysmal wall enhancement, thrombus) with specific syndromes like HSS.

Main Results:

• Pulmonary artery aneurysms with specific imaging characteristics (wall enhancement, in-situ thrombus) are highly suggestive of HSS.
• Prompt recognition of HSS can guide appropriate treatment strategies.
• Exclusion of other potential causes is a critical step in the diagnostic pathway.

Conclusions:

• Hughes-Stovin Syndrome (HSS) should be strongly suspected in patients presenting with pulmonary artery aneurysms, especially with characteristic imaging findings.
• Early initiation of immunosuppressive therapy and consideration of endovascular interventions in selected HSS cases can prevent fatal hemoptysis.
• Comprehensive evaluation is essential for accurate diagnosis and improved management of pulmonary artery bleeding.